A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Repligen Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 34,271 shares of RGEN stock, worth $5.05 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
34,271
Previous 14,484 136.61%
Holding current value
$5.05 Million
Previous $1.83 Million 179.45%
% of portfolio
0.03%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$119.79 - $167.35 $2.37 Million - $3.31 Million
19,787 Added 136.61%
34,271 $5.1 Million
Q2 2024

Aug 09, 2024

BUY
$120.0 - $182.95 $1.74 Million - $2.65 Million
14,484 New
14,484 $1.83 Million
Q2 2023

Aug 10, 2023

SELL
$138.42 - $180.31 $1.36 Million - $1.78 Million
-9,856 Reduced 70.26%
4,172 $590,000
Q1 2023

May 09, 2023

SELL
$154.26 - $198.1 $455,992 - $585,583
-2,956 Reduced 17.4%
14,028 $2.36 Million
Q4 2022

Feb 10, 2023

BUY
$162.42 - $220.56 $2.76 Million - $3.75 Million
16,984 New
16,984 $2.88 Million
Q4 2020

Feb 16, 2021

SELL
$148.08 - $206.57 $3.08 Million - $4.29 Million
-20,789 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$122.51 - $158.27 $1.91 Million - $2.47 Million
15,605 Added 301.02%
20,789 $3.07 Million
Q2 2020

Aug 13, 2020

SELL
$94.33 - $140.48 $3.52 Million - $5.24 Million
-37,317 Reduced 87.8%
5,184 $641,000
Q1 2020

May 13, 2020

BUY
$84.96 - $109.14 $1.2 Million - $1.55 Million
14,178 Added 50.06%
42,501 $4.1 Million
Q4 2019

Feb 12, 2020

BUY
$73.84 - $93.08 $2.09 Million - $2.64 Million
28,323 New
28,323 $2.62 Million
Q2 2019

Aug 07, 2019

SELL
$54.2 - $85.95 $280,485 - $444,791
-5,175 Closed
0 $0
Q1 2019

May 08, 2019

SELL
$49.45 - $62.8 $32,142 - $40,820
-650 Reduced 11.16%
5,175 $306,000
Q4 2018

Feb 12, 2019

BUY
$48.26 - $68.88 $281,114 - $401,226
5,825 New
5,825 $307,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.18B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.